Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood-brain-barrier Permeability of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene: Effect on Sleep and Procedural Learning

NCT00550485 is registered in ClinicalTrials.gov with Max-Planck-Institute of Psychiatry as lead sponsor.

NCT NCT00550485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00550485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood-brain-barrier Permeability of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene: Effect on Sleep and Procedural Learning
Lead sponsor
Max-Planck-Institute of Psychiatry
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2007
Completion date
July 6, 2018
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics